Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauri E Markowitz

Showing results (221-230 of 290) with videos related to

Pageof 29
Sort By:
Sexually Transmitted Diseases|October 8, 2009
HPV 6/11, 16, 18 seroprevalence in men in two US citiesEileen F Dunne, Carrie M Nielson, Michael E Hagensee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2014
HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United StatesSusan Hariri, Elizabeth R Unger, Sean Schafer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 10, 2011
Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, CaliforniaRachel Robitz, Sami L Gottlieb, Christine J De Rosa, et al.
Vaccine|November 10, 2012
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesionsSuzanne E Powell, Susan Hariri, Martin Steinau, et al.
The Journal of Infectious Diseases|October 10, 2012
Human papillomavirus genotypes in high-grade cervical lesions in the United StatesSusan Hariri, Elizabeth R Unger, Suzanne E Powell, et al.
The Journal of Infectious Diseases|July 28, 2021
Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender WomenRachel L Winer, John Lin, Troy D Querec, et al.
BMC Infectious Diseases|February 23, 2022
HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoringNancy McClung, Anikie Mathoma, Julia W Gargano, et al.
Vaccine|October 7, 2025
HPV vaccination among gay, bisexual, and other men who have sex with men aged 27-45 years in the United States is potentially Cost-savingPatrick A Clay, Lauri E Markowitz, Sameer V Gopalani, et al.
Vaccine|April 16, 2024
Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccinationBionca M Davis, Ian Blake, Gitika Panicker, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|May 13, 2021
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018Peng-Jun Lu, Mei-Chuan Hung, Anup Srivastav, et al.
Pageof 29

Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
Sexually Transmitted Diseases|October 8, 2009
HPV 6/11, 16, 18 seroprevalence in men in two US citiesEileen F Dunne, Carrie M Nielson, Michael E Hagensee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2014
HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United StatesSusan Hariri, Elizabeth R Unger, Sean Schafer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 10, 2011
Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, CaliforniaRachel Robitz, Sami L Gottlieb, Christine J De Rosa, et al.
Vaccine|November 10, 2012
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesionsSuzanne E Powell, Susan Hariri, Martin Steinau, et al.
The Journal of Infectious Diseases|October 10, 2012
Human papillomavirus genotypes in high-grade cervical lesions in the United StatesSusan Hariri, Elizabeth R Unger, Suzanne E Powell, et al.
The Journal of Infectious Diseases|July 28, 2021
Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender WomenRachel L Winer, John Lin, Troy D Querec, et al.
BMC Infectious Diseases|February 23, 2022
HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoringNancy McClung, Anikie Mathoma, Julia W Gargano, et al.
Vaccine|October 7, 2025
HPV vaccination among gay, bisexual, and other men who have sex with men aged 27-45 years in the United States is potentially Cost-savingPatrick A Clay, Lauri E Markowitz, Sameer V Gopalani, et al.
Vaccine|April 16, 2024
Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccinationBionca M Davis, Ian Blake, Gitika Panicker, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|May 13, 2021
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018Peng-Jun Lu, Mei-Chuan Hung, Anup Srivastav, et al.
Pageof 29